SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-19-272703
Filing Date
2019-10-23
Accepted
2019-10-23 17:25:12
Documents
14
Period of Report
2019-10-23
Items
Item 2.02: Results of Operations and Financial Condition
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d812478d8k.htm   iXBRL 8-K 29282
2 EX-99.1 d812478dex991.htm EX-99.1 12678
6 GRAPHIC g812478g1024021315601.jpg GRAPHIC 3922
  Complete submission text file 0001193125-19-272703.txt   175906

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA txmd-20191023.xsd EX-101.SCH 3077
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE txmd-20191023_lab.xml EX-101.LAB 18140
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE txmd-20191023_pre.xml EX-101.PRE 11413
11 EXTRACTED XBRL INSTANCE DOCUMENT d812478d8k_htm.xml XML 3353
Mailing Address 951 YAMATO ROAD, SUITE 220 BOCA RATON FL 33431
Business Address 951 YAMATO ROAD, SUITE 220 BOCA RATON FL 33431 561-961-1900
TherapeuticsMD, Inc. (Filer) CIK: 0000025743 (see all company filings)

IRS No.: 870233535 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-00100 | Film No.: 191164447
SIC: 2834 Pharmaceutical Preparations